Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
24.28
-1.05 (-4.15%)
At close: Jun 6, 2025, 4:00 PM
25.40
+1.12 (4.61%)
After-hours: Jun 6, 2025, 7:59 PM EDT
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $32.18 million as of June 6, 2025. Its market cap has increased by 48.52% in one year.
Market Cap
32.18M
Enterprise Value
33.80M
1-Year Change
48.52%
Ranking
Category
Stock Price
$24.28
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from $230.14M to $32.18M, a decrease of -86.02%. That is a compound annual growth rate of -32.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 32.18M | 138.18% |
| Dec 31, 2024 | 13.51M | -95.09% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | 147.37M | -35.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.38B |
| Johnson & Johnson | 369.72B |
| AbbVie | 331.15B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 268.37B |
| Abbott Laboratories | 233.03B |
| Novartis AG | 230.96B |
| AstraZeneca | 225.55B |